0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharma Continuous Granulation Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-2L18119
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharma Continuous Granulation Market Research Report 2024
BUY CHAPTERS

Global Pharma Continuous Granulation Market Research Report 2024

Code: QYRE-Auto-2L18119
Report
August 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharma Continuous Granulation Market

Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
The global Pharma Continuous Granulation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pharma Continuous Granulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pharma Continuous Granulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pharma Continuous Granulation include LB Bohle, GEA, LCI, LÖDIGE, Senieer, Thermo Fisher Scientific, Syntegon, Gericke, Bepex, EARTHTECHNICA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharma Continuous Granulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Continuous Granulation.
The Pharma Continuous Granulation market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma Continuous Granulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Continuous Granulation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharma Continuous Granulation Market Report

Report Metric Details
Report Name Pharma Continuous Granulation Market
by Type
by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company LB Bohle, GEA, LCI, LÖDIGE, Senieer, Thermo Fisher Scientific, Syntegon, Gericke, Bepex, EARTHTECHNICA, Glatt, FREUND, Chansemt
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharma Continuous Granulation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Pharma Continuous Granulation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Pharma Continuous Granulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharma Continuous Granulation Market report?

Ans: The main players in the Pharma Continuous Granulation Market are LB Bohle, GEA, LCI, LÖDIGE, Senieer, Thermo Fisher Scientific, Syntegon, Gericke, Bepex, EARTHTECHNICA, Glatt, FREUND, Chansemt

What are the Application segmentation covered in the Pharma Continuous Granulation Market report?

Ans: The Applications covered in the Pharma Continuous Granulation Market report are Tablets, Capsules, Others

What are the Type segmentation covered in the Pharma Continuous Granulation Market report?

Ans: The Types covered in the Pharma Continuous Granulation Market report are Dry Method, Wet Method

Recommended Reports

Granulation Equipment

Pharma Processing

Continuous Manufacturing

1 Pharma Continuous Granulation Market Overview
1.1 Product Definition
1.2 Pharma Continuous Granulation by Type
1.2.1 Global Pharma Continuous Granulation Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Dry Method
1.2.3 Wet Method
1.3 Pharma Continuous Granulation by Application
1.3.1 Global Pharma Continuous Granulation Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharma Continuous Granulation Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Pharma Continuous Granulation Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Pharma Continuous Granulation Production Estimates and Forecasts (2019-2030)
1.4.4 Global Pharma Continuous Granulation Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharma Continuous Granulation Production Market Share by Manufacturers (2019-2024)
2.2 Global Pharma Continuous Granulation Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Pharma Continuous Granulation, Industry Ranking, 2022 VS 2023
2.4 Global Pharma Continuous Granulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharma Continuous Granulation Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Pharma Continuous Granulation, Manufacturing Sites & Headquarters
2.7 Global Key Manufacturers of Pharma Continuous Granulation, Product Type & Application
2.8 Global Key Manufacturers of Pharma Continuous Granulation, Date of Enter into This Industry
2.9 Global Pharma Continuous Granulation Market Competitive Situation and Trends
2.9.1 Global Pharma Continuous Granulation Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharma Continuous Granulation Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharma Continuous Granulation Production by Region
3.1 Global Pharma Continuous Granulation Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Pharma Continuous Granulation Production Value by Region (2019-2030)
3.2.1 Global Pharma Continuous Granulation Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Pharma Continuous Granulation by Region (2025-2030)
3.3 Global Pharma Continuous Granulation Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Pharma Continuous Granulation Production by Region (2019-2030)
3.4.1 Global Pharma Continuous Granulation Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Pharma Continuous Granulation by Region (2025-2030)
3.5 Global Pharma Continuous Granulation Market Price Analysis by Region (2019-2024)
3.6 Global Pharma Continuous Granulation Production and Value, Year-over-Year Growth
3.6.1 North America Pharma Continuous Granulation Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Pharma Continuous Granulation Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Pharma Continuous Granulation Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Pharma Continuous Granulation Production Value Estimates and Forecasts (2019-2030)
4 Pharma Continuous Granulation Consumption by Region
4.1 Global Pharma Continuous Granulation Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Pharma Continuous Granulation Consumption by Region (2019-2030)
4.2.1 Global Pharma Continuous Granulation Consumption by Region (2019-2030)
4.2.2 Global Pharma Continuous Granulation Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Pharma Continuous Granulation Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Pharma Continuous Granulation Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Netherlands
4.5 Asia Pacific
4.5.1 Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Pharma Continuous Granulation Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharma Continuous Granulation Production by Type (2019-2030)
5.1.1 Global Pharma Continuous Granulation Production by Type (2019-2024)
5.1.2 Global Pharma Continuous Granulation Production by Type (2025-2030)
5.1.3 Global Pharma Continuous Granulation Production Market Share by Type (2019-2030)
5.2 Global Pharma Continuous Granulation Production Value by Type (2019-2030)
5.2.1 Global Pharma Continuous Granulation Production Value by Type (2019-2024)
5.2.2 Global Pharma Continuous Granulation Production Value by Type (2025-2030)
5.2.3 Global Pharma Continuous Granulation Production Value Market Share by Type (2019-2030)
5.3 Global Pharma Continuous Granulation Price by Type (2019-2030)
6 Segment by Application
6.1 Global Pharma Continuous Granulation Production by Application (2019-2030)
6.1.1 Global Pharma Continuous Granulation Production by Application (2019-2024)
6.1.2 Global Pharma Continuous Granulation Production by Application (2025-2030)
6.1.3 Global Pharma Continuous Granulation Production Market Share by Application (2019-2030)
6.2 Global Pharma Continuous Granulation Production Value by Application (2019-2030)
6.2.1 Global Pharma Continuous Granulation Production Value by Application (2019-2024)
6.2.2 Global Pharma Continuous Granulation Production Value by Application (2025-2030)
6.2.3 Global Pharma Continuous Granulation Production Value Market Share by Application (2019-2030)
6.3 Global Pharma Continuous Granulation Price by Application (2019-2030)
7 Key Companies Profiled
7.1 LB Bohle
7.1.1 LB Bohle Pharma Continuous Granulation Company Information
7.1.2 LB Bohle Pharma Continuous Granulation Product Portfolio
7.1.3 LB Bohle Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.1.4 LB Bohle Main Business and Markets Served
7.1.5 LB Bohle Recent Developments/Updates
7.2 GEA
7.2.1 GEA Pharma Continuous Granulation Company Information
7.2.2 GEA Pharma Continuous Granulation Product Portfolio
7.2.3 GEA Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.2.4 GEA Main Business and Markets Served
7.2.5 GEA Recent Developments/Updates
7.3 LCI
7.3.1 LCI Pharma Continuous Granulation Company Information
7.3.2 LCI Pharma Continuous Granulation Product Portfolio
7.3.3 LCI Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.3.4 LCI Main Business and Markets Served
7.3.5 LCI Recent Developments/Updates
7.4 LÖDIGE
7.4.1 LÖDIGE Pharma Continuous Granulation Company Information
7.4.2 LÖDIGE Pharma Continuous Granulation Product Portfolio
7.4.3 LÖDIGE Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.4.4 LÖDIGE Main Business and Markets Served
7.4.5 LÖDIGE Recent Developments/Updates
7.5 Senieer
7.5.1 Senieer Pharma Continuous Granulation Company Information
7.5.2 Senieer Pharma Continuous Granulation Product Portfolio
7.5.3 Senieer Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Senieer Main Business and Markets Served
7.5.5 Senieer Recent Developments/Updates
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Pharma Continuous Granulation Company Information
7.6.2 Thermo Fisher Scientific Pharma Continuous Granulation Product Portfolio
7.6.3 Thermo Fisher Scientific Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Thermo Fisher Scientific Main Business and Markets Served
7.6.5 Thermo Fisher Scientific Recent Developments/Updates
7.7 Syntegon
7.7.1 Syntegon Pharma Continuous Granulation Company Information
7.7.2 Syntegon Pharma Continuous Granulation Product Portfolio
7.7.3 Syntegon Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Syntegon Main Business and Markets Served
7.7.5 Syntegon Recent Developments/Updates
7.8 Gericke
7.8.1 Gericke Pharma Continuous Granulation Company Information
7.8.2 Gericke Pharma Continuous Granulation Product Portfolio
7.8.3 Gericke Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Gericke Main Business and Markets Served
7.8.5 Gericke Recent Developments/Updates
7.9 Bepex
7.9.1 Bepex Pharma Continuous Granulation Company Information
7.9.2 Bepex Pharma Continuous Granulation Product Portfolio
7.9.3 Bepex Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Bepex Main Business and Markets Served
7.9.5 Bepex Recent Developments/Updates
7.10 EARTHTECHNICA
7.10.1 EARTHTECHNICA Pharma Continuous Granulation Company Information
7.10.2 EARTHTECHNICA Pharma Continuous Granulation Product Portfolio
7.10.3 EARTHTECHNICA Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.10.4 EARTHTECHNICA Main Business and Markets Served
7.10.5 EARTHTECHNICA Recent Developments/Updates
7.11 Glatt
7.11.1 Glatt Pharma Continuous Granulation Company Information
7.11.2 Glatt Pharma Continuous Granulation Product Portfolio
7.11.3 Glatt Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Glatt Main Business and Markets Served
7.11.5 Glatt Recent Developments/Updates
7.12 FREUND
7.12.1 FREUND Pharma Continuous Granulation Company Information
7.12.2 FREUND Pharma Continuous Granulation Product Portfolio
7.12.3 FREUND Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.12.4 FREUND Main Business and Markets Served
7.12.5 FREUND Recent Developments/Updates
7.13 Chansemt
7.13.1 Chansemt Pharma Continuous Granulation Company Information
7.13.2 Chansemt Pharma Continuous Granulation Product Portfolio
7.13.3 Chansemt Pharma Continuous Granulation Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Chansemt Main Business and Markets Served
7.13.5 Chansemt Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharma Continuous Granulation Industry Chain Analysis
8.2 Pharma Continuous Granulation Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharma Continuous Granulation Production Mode & Process
8.4 Pharma Continuous Granulation Sales and Marketing
8.4.1 Pharma Continuous Granulation Sales Channels
8.4.2 Pharma Continuous Granulation Distributors
8.5 Pharma Continuous Granulation Customers
9 Pharma Continuous Granulation Market Dynamics
9.1 Pharma Continuous Granulation Industry Trends
9.2 Pharma Continuous Granulation Market Drivers
9.3 Pharma Continuous Granulation Market Challenges
9.4 Pharma Continuous Granulation Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Pharma Continuous Granulation Market Value by Type, (US$ Million) & (2023 VS 2030)
 Table 2. Global Pharma Continuous Granulation Market Value by Application, (US$ Million) & (2023 VS 2030)
 Table 3. Global Pharma Continuous Granulation Production by Manufacturers (2019-2024) & (K Units)
 Table 4. Global Pharma Continuous Granulation Production Market Share by Manufacturers (2019-2024)
 Table 5. Global Pharma Continuous Granulation Production Value by Manufacturers (2019-2024) & (US$ Million)
 Table 6. Global Pharma Continuous Granulation Production Value Share by Manufacturers (2019-2024)
 Table 7. Global Key Players of Pharma Continuous Granulation, Industry Ranking, 2022 VS 2023
 Table 8. Global Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pharma Continuous Granulation as of 2023)
 Table 9. Global Market Pharma Continuous Granulation Average Price by Manufacturers (US$/Unit) & (2019-2024)
 Table 10. Global Key Manufacturers of Pharma Continuous Granulation, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pharma Continuous Granulation, Product Type & Application
 Table 12. Global Key Manufacturers of Pharma Continuous Granulation, Date of Enter into This Industry
 Table 13. Global Pharma Continuous Granulation Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Mergers & Acquisitions, Expansion Plans
 Table 15. Global Pharma Continuous Granulation Production Value Growth Rate by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 16. Global Pharma Continuous Granulation Production Value (US$ Million) by Region (2019-2024)
 Table 17. Global Pharma Continuous Granulation Production Value Market Share by Region (2019-2024)
 Table 18. Global Pharma Continuous Granulation Production Value (US$ Million) Forecast by Region (2025-2030)
 Table 19. Global Pharma Continuous Granulation Production Value Market Share Forecast by Region (2025-2030)
 Table 20. Global Pharma Continuous Granulation Production Comparison by Region: 2019 VS 2023 VS 2030 (K Units)
 Table 21. Global Pharma Continuous Granulation Production (K Units) by Region (2019-2024)
 Table 22. Global Pharma Continuous Granulation Production Market Share by Region (2019-2024)
 Table 23. Global Pharma Continuous Granulation Production (K Units) Forecast by Region (2025-2030)
 Table 24. Global Pharma Continuous Granulation Production Market Share Forecast by Region (2025-2030)
 Table 25. Global Pharma Continuous Granulation Market Average Price (US$/Unit) by Region (2019-2024)
 Table 26. Global Pharma Continuous Granulation Market Average Price (US$/Unit) by Region (2025-2030)
 Table 27. Global Pharma Continuous Granulation Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (K Units)
 Table 28. Global Pharma Continuous Granulation Consumption by Region (2019-2024) & (K Units)
 Table 29. Global Pharma Continuous Granulation Consumption Market Share by Region (2019-2024)
 Table 30. Global Pharma Continuous Granulation Forecasted Consumption by Region (2025-2030) & (K Units)
 Table 31. Global Pharma Continuous Granulation Forecasted Consumption Market Share by Region (2019-2024)
 Table 32. North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
 Table 33. North America Pharma Continuous Granulation Consumption by Country (2019-2024) & (K Units)
 Table 34. North America Pharma Continuous Granulation Consumption by Country (2025-2030) & (K Units)
 Table 35. Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
 Table 36. Europe Pharma Continuous Granulation Consumption by Country (2019-2024) & (K Units)
 Table 37. Europe Pharma Continuous Granulation Consumption by Country (2025-2030) & (K Units)
 Table 38. Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
 Table 39. Asia Pacific Pharma Continuous Granulation Consumption by Region (2019-2024) & (K Units)
 Table 40. Asia Pacific Pharma Continuous Granulation Consumption by Region (2025-2030) & (K Units)
 Table 41. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
 Table 42. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (2019-2024) & (K Units)
 Table 43. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (2025-2030) & (K Units)
 Table 44. Global Pharma Continuous Granulation Production (K Units) by Type (2019-2024)
 Table 45. Global Pharma Continuous Granulation Production (K Units) by Type (2025-2030)
 Table 46. Global Pharma Continuous Granulation Production Market Share by Type (2019-2024)
 Table 47. Global Pharma Continuous Granulation Production Market Share by Type (2025-2030)
 Table 48. Global Pharma Continuous Granulation Production Value (US$ Million) by Type (2019-2024)
 Table 49. Global Pharma Continuous Granulation Production Value (US$ Million) by Type (2025-2030)
 Table 50. Global Pharma Continuous Granulation Production Value Market Share by Type (2019-2024)
 Table 51. Global Pharma Continuous Granulation Production Value Market Share by Type (2025-2030)
 Table 52. Global Pharma Continuous Granulation Price (US$/Unit) by Type (2019-2024)
 Table 53. Global Pharma Continuous Granulation Price (US$/Unit) by Type (2025-2030)
 Table 54. Global Pharma Continuous Granulation Production (K Units) by Application (2019-2024)
 Table 55. Global Pharma Continuous Granulation Production (K Units) by Application (2025-2030)
 Table 56. Global Pharma Continuous Granulation Production Market Share by Application (2019-2024)
 Table 57. Global Pharma Continuous Granulation Production Market Share by Application (2025-2030)
 Table 58. Global Pharma Continuous Granulation Production Value (US$ Million) by Application (2019-2024)
 Table 59. Global Pharma Continuous Granulation Production Value (US$ Million) by Application (2025-2030)
 Table 60. Global Pharma Continuous Granulation Production Value Market Share by Application (2019-2024)
 Table 61. Global Pharma Continuous Granulation Production Value Market Share by Application (2025-2030)
 Table 62. Global Pharma Continuous Granulation Price (US$/Unit) by Application (2019-2024)
 Table 63. Global Pharma Continuous Granulation Price (US$/Unit) by Application (2025-2030)
 Table 64. LB Bohle Pharma Continuous Granulation Company Information
 Table 65. LB Bohle Pharma Continuous Granulation Specification and Application
 Table 66. LB Bohle Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 67. LB Bohle Main Business and Markets Served
 Table 68. LB Bohle Recent Developments/Updates
 Table 69. GEA Pharma Continuous Granulation Company Information
 Table 70. GEA Pharma Continuous Granulation Specification and Application
 Table 71. GEA Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 72. GEA Main Business and Markets Served
 Table 73. GEA Recent Developments/Updates
 Table 74. LCI Pharma Continuous Granulation Company Information
 Table 75. LCI Pharma Continuous Granulation Specification and Application
 Table 76. LCI Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 77. LCI Main Business and Markets Served
 Table 78. LCI Recent Developments/Updates
 Table 79. LÖDIGE Pharma Continuous Granulation Company Information
 Table 80. LÖDIGE Pharma Continuous Granulation Specification and Application
 Table 81. LÖDIGE Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 82. LÖDIGE Main Business and Markets Served
 Table 83. LÖDIGE Recent Developments/Updates
 Table 84. Senieer Pharma Continuous Granulation Company Information
 Table 85. Senieer Pharma Continuous Granulation Specification and Application
 Table 86. Senieer Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 87. Senieer Main Business and Markets Served
 Table 88. Senieer Recent Developments/Updates
 Table 89. Thermo Fisher Scientific Pharma Continuous Granulation Company Information
 Table 90. Thermo Fisher Scientific Pharma Continuous Granulation Specification and Application
 Table 91. Thermo Fisher Scientific Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 92. Thermo Fisher Scientific Main Business and Markets Served
 Table 93. Thermo Fisher Scientific Recent Developments/Updates
 Table 94. Syntegon Pharma Continuous Granulation Company Information
 Table 95. Syntegon Pharma Continuous Granulation Specification and Application
 Table 96. Syntegon Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 97. Syntegon Main Business and Markets Served
 Table 98. Syntegon Recent Developments/Updates
 Table 99. Gericke Pharma Continuous Granulation Company Information
 Table 100. Gericke Pharma Continuous Granulation Specification and Application
 Table 101. Gericke Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 102. Gericke Main Business and Markets Served
 Table 103. Gericke Recent Developments/Updates
 Table 104. Bepex Pharma Continuous Granulation Company Information
 Table 105. Bepex Pharma Continuous Granulation Specification and Application
 Table 106. Bepex Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 107. Bepex Main Business and Markets Served
 Table 108. Bepex Recent Developments/Updates
 Table 109. EARTHTECHNICA Pharma Continuous Granulation Company Information
 Table 110. EARTHTECHNICA Pharma Continuous Granulation Specification and Application
 Table 111. EARTHTECHNICA Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 112. EARTHTECHNICA Main Business and Markets Served
 Table 113. EARTHTECHNICA Recent Developments/Updates
 Table 114. Glatt Pharma Continuous Granulation Company Information
 Table 115. Glatt Pharma Continuous Granulation Specification and Application
 Table 116. Glatt Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 117. Glatt Main Business and Markets Served
 Table 118. Glatt Recent Developments/Updates
 Table 119. FREUND Pharma Continuous Granulation Company Information
 Table 120. FREUND Pharma Continuous Granulation Specification and Application
 Table 121. FREUND Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 122. FREUND Main Business and Markets Served
 Table 123. FREUND Recent Developments/Updates
 Table 124. Chansemt Pharma Continuous Granulation Company Information
 Table 125. Chansemt Pharma Continuous Granulation Specification and Application
 Table 126. Chansemt Pharma Continuous Granulation Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 127. Chansemt Main Business and Markets Served
 Table 128. Chansemt Recent Developments/Updates
 Table 129. Key Raw Materials Lists
 Table 130. Raw Materials Key Suppliers Lists
 Table 131. Pharma Continuous Granulation Distributors List
 Table 132. Pharma Continuous Granulation Customers List
 Table 133. Pharma Continuous Granulation Market Trends
 Table 134. Pharma Continuous Granulation Market Drivers
 Table 135. Pharma Continuous Granulation Market Challenges
 Table 136. Pharma Continuous Granulation Market Restraints
 Table 137. Research Programs/Design for This Report
 Table 138. Key Data Information from Secondary Sources
 Table 139. Key Data Information from Primary Sources
 Table 140. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharma Continuous Granulation
 Figure 2. Global Pharma Continuous Granulation Market Value by Type, (US$ Million) & (2023 VS 2030)
 Figure 3. Global Pharma Continuous Granulation Market Share by Type: 2023 VS 2030
 Figure 4. Dry Method Product Picture
 Figure 5. Wet Method Product Picture
 Figure 6. Global Pharma Continuous Granulation Market Value by Application, (US$ Million) & (2023 VS 2030)
 Figure 7. Global Pharma Continuous Granulation Market Share by Application: 2023 VS 2030
 Figure 8. Tablets
 Figure 9. Capsules
 Figure 10. Others
 Figure 11. Global Pharma Continuous Granulation Production Value (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Pharma Continuous Granulation Production Value (US$ Million) & (2019-2030)
 Figure 13. Global Pharma Continuous Granulation Production Capacity (K Units) & (2019-2030)
 Figure 14. Global Pharma Continuous Granulation Production (K Units) & (2019-2030)
 Figure 15. Global Pharma Continuous Granulation Average Price (US$/Unit) & (2019-2030)
 Figure 16. Pharma Continuous Granulation Report Years Considered
 Figure 17. Pharma Continuous Granulation Production Share by Manufacturers in 2023
 Figure 18. Pharma Continuous Granulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Pharma Continuous Granulation Revenue in 2023
 Figure 20. Global Pharma Continuous Granulation Production Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 21. Global Pharma Continuous Granulation Production Value Market Share by Region: 2019 VS 2023 VS 2030
 Figure 22. Global Pharma Continuous Granulation Production Comparison by Region: 2019 VS 2023 VS 2030 (K Units)
 Figure 23. Global Pharma Continuous Granulation Production Market Share by Region: 2019 VS 2023 VS 2030
 Figure 24. North America Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2019-2030)
 Figure 25. Europe Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2019-2030)
 Figure 26. China Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2019-2030)
 Figure 27. Japan Pharma Continuous Granulation Production Value (US$ Million) Growth Rate (2019-2030)
 Figure 28. Global Pharma Continuous Granulation Consumption by Region: 2019 VS 2023 VS 2030 (K Units)
 Figure 29. Global Pharma Continuous Granulation Consumption Market Share by Region: 2019 VS 2023 VS 2030
 Figure 30. North America Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 31. North America Pharma Continuous Granulation Consumption Market Share by Country (2019-2030)
 Figure 32. U.S. Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 33. Canada Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 34. Europe Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 35. Europe Pharma Continuous Granulation Consumption Market Share by Country (2019-2030)
 Figure 36. Germany Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 37. France Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 38. U.K. Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 39. Italy Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 40. Netherlands Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 41. Asia Pacific Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 42. Asia Pacific Pharma Continuous Granulation Consumption Market Share by Region (2025-2030)
 Figure 43. China Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 44. Japan Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 45. South Korea Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 46. China Taiwan Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 47. Southeast Asia Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 48. India Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 49. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 50. Latin America, Middle East & Africa Pharma Continuous Granulation Consumption Market Share by Country (2019-2030)
 Figure 51. Mexico Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 52. Brazil Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 53. Turkey Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 54. GCC Countries Pharma Continuous Granulation Consumption and Growth Rate (2019-2030) & (K Units)
 Figure 55. Global Production Market Share of Pharma Continuous Granulation by Type (2019-2030)
 Figure 56. Global Production Value Market Share of Pharma Continuous Granulation by Type (2019-2030)
 Figure 57. Global Pharma Continuous Granulation Price (US$/Unit) by Type (2019-2030)
 Figure 58. Global Production Market Share of Pharma Continuous Granulation by Application (2019-2030)
 Figure 59. Global Production Value Market Share of Pharma Continuous Granulation by Application (2019-2030)
 Figure 60. Global Pharma Continuous Granulation Price (US$/Unit) by Application (2019-2030)
 Figure 61. Pharma Continuous Granulation Value Chain
 Figure 62. Pharma Continuous Granulation Production Process
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart